In recent days, the United Nations Global Compact (UNGC) Liaison Office in China held the 2024-2025 Corporate Accelerator Program Annual Meeting in Beijing. Jiuzhou Pharma, as one of the participating companies, was awarded the completion certificate of the UNGC SDG Ambition Accelerator (2024).

The SDG Ambition Accelerator (SDGA) is a capability-building program lasting three to six months that aims to challenge and support members of the UNGC to set ambitious corporate goals and accelerate the integration of the 17 United Nations Sustainable Development Goals with core business management, creating long-term value for their business and the society in which they operate.

Jiuzhou Pharma attaches great importance to sustainable development. This year, the company's ESG executive committee initiated the "Sustainable Development Planning Project", requiring each business department to set five-year (2025-2030) ESG management goals based on global policy trends and customer ESG target setting, for the important issues identified by the company. The ESG Executive Committee has submitted a proposal for the "Key ESG Objectives of Jiuzhou Pharma" to the Board of Directors' Strategic Decision-making Committee and has been reviewed and approved. In addition, the company has also recently applied to join the "Science-Based Targets Initiative" (SBTi).

In recent days, the United Nations Global Compact (UNGC) Liaison Office in China held the 2024-2025 Corporate Accelerator Program Annual Meeting in Beijing. Jiuzhou Pharma, as one of the participating companies, was awarded the completion certificate of the UNGC SDG Ambition Accelerator (2024).

The SDG Ambition Accelerator (SDGA) is a capability-building program lasting three to six months that aims to challenge and support members of the UNGC to set ambitious corporate goals and accelerate the integration of the 17 United Nations Sustainable Development Goals with core business management, creating long-term value for their business and the society in which they operate.

Jiuzhou Pharma attaches great importance to sustainable development. This year, the company's ESG executive committee initiated the "Sustainable Development Planning Project", requiring each business department to set five-year (2025-2030) ESG management goals based on global policy trends and customer ESG target setting, for the important issues identified by the company. The ESG Executive Committee has submitted a proposal for the "Key ESG Objectives of Jiuzhou Pharma" to the Board of Directors' Strategic Decision-making Committee and has been reviewed and approved. In addition, the company has also recently applied to join the "Science-Based Targets Initiative" (SBTi).

In recent days, the United Nations Global Compact (UNGC) Liaison Office in China held the 2024-2025 Corporate Accelerator Program Annual Meeting in Beijing. Jiuzhou Pharma, as one of the participating companies, was awarded the completion certificate of the UNGC SDG Ambition Accelerator (2024).

The SDG Ambition Accelerator (SDGA) is a capability-building program lasting three to six months that aims to challenge and support members of the UNGC to set ambitious corporate goals and accelerate the integration of the 17 United Nations Sustainable Development Goals with core business management, creating long-term value for their business and the society in which they operate.

Jiuzhou Pharma attaches great importance to sustainable development. This year, the company's ESG executive committee initiated the "Sustainable Development Planning Project", requiring each business department to set five-year (2025-2030) ESG management goals based on global policy trends and customer ESG target setting, for the important issues identified by the company. The ESG Executive Committee has submitted a proposal for the "Key ESG Objectives of Jiuzhou Pharma" to the Board of Directors' Strategic Decision-making Committee and has been reviewed and approved. In addition, the company has also recently applied to join the "Science-Based Targets Initiative" (SBTi).